A French lysine producer has filed a complaint with the European Union saying that a reduction in prices for Chinese lysine has made penalties to stop unfair pricing ineffective, according to a Reuters report.
Eurolysine, a unit of Avril Group and the EU’s only fermentation-based amino acid producer, said market conditions for lysine, valine and tryptophan had worsened for more than six months, arguing that Chinese prices have fallen below production costs.
Lysine prices are 20% lower than in July 2024, while tryptophan has dropped 60% from a year ago, Eurolysine said.
In January 2025, the European Commission (EC) announced it was imposing a provisional anti-dumping tariff on imports of lysine from the China. This came after the EU opened an anti-dumping investigation into imports into the trading bloc of lysine originating in China in May 2024. Products involved were defined as “lysine and its esters, salt thereof, and feed additives consisting on a dry weight basis of between 68% and 80% of L-lysine sulfate, and not more than 32% of other components” from China.
After detailed and complex investigations involving participants from the EU and China, the EC proposed anti-dumping duty rates of between 58.3% and 84.8%. These apply to the cost, insurance and freight (CIF) union border price, and prior to customs duties. The duty rates vary between different Chinese manufacturers.
Eurolysine said it filed a new complaint with the European Commission on February 11, seeking an anti-absorption investigation to ensure tariffs reflect continued undercutting by Chinese suppliers.
